Actinogen Medical Limited (ASX:ACW)
Australia flag Australia · Delayed Price · Currency is AUD
0.0580
-0.0010 (-1.69%)
Sep 10, 2026, 4:10 PM AEST

Actinogen Medical Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
12.6712.675.499.934.893.64
Revenue Growth
72.11%130.87%-44.73%103.18%34.28%83.47%
Gross Profit
12.6712.675.499.934.893.64
Operating Income
-15.44-15.44-15.35-13.26-10.99-9.53
Net Income
-15.38-15.38-14.73-13.04-10.75-9.5
Earnings Per Share
-0.00-0.00-0.00-0.01-0.01-0.01
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
16.7316.7316.59.458.4616.37
Total Debt
4.784.783.260.320.090.17
Net Cash (Debt)
11.9511.9513.249.138.3716.21
Net Cash Growth
89.48%-9.73%44.99%9.06%-48.33%22.57%
Net Cash Per Share
0.000.000.000.000.000.01

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-17.56-17.56-7.56-16.95-8.7-9.52
Capital Expenditures
-0.01-0.01-0.04-0.01-0.04-0
Free Cash Flow
-17.57-17.57-7.59-16.96-8.73-9.52
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-121.82%-121.82%-279.70%-133.47%-224.74%-261.90%
Pretax Margin
-121.35%-121.35%-268.37%-131.34%-219.98%-260.91%
Profit Margin
-121.35%-121.35%-268.37%-131.34%-219.98%-260.91%
FCF Margin
-138.63%-138.63%-138.33%-170.76%-178.70%-261.53%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
17.028.9513.3116.7514.8624.67